Figures & data
Figure 1 Scanning electron microscopy demonstrating mature fungal biofilms that were formed in 24-well plates. White arrows depict extracellular matrix covering and connecting the hyphae. (A) Trichophyton rubrum ATCC 28189. (B) Trichophyton mentagrophytes ATCC 11481. Reprinted from J Am Acad Dermatol, 1;80(4), Lipner SR, Scher RK, Onychomycosis: Clinical overview and diagnosis, 835–851, Copyright (2019), with permission from Elsevier.Citation4
![Figure 1 Scanning electron microscopy demonstrating mature fungal biofilms that were formed in 24-well plates. White arrows depict extracellular matrix covering and connecting the hyphae. (A) Trichophyton rubrum ATCC 28189. (B) Trichophyton mentagrophytes ATCC 11481. Reprinted from J Am Acad Dermatol, 1;80(4), Lipner SR, Scher RK, Onychomycosis: Clinical overview and diagnosis, 835–851, Copyright (2019), with permission from Elsevier.Citation4](/cms/asset/507779ce-0ef1-4a43-b8c0-43ba3a12e1e0/dcci_a_12152511_f0001_c.jpg)
Figure 2 Patient with laboratory confirmed onychomycosis. (A) Clinical appearance of toenails with onycholysis, nail plate thickening and subungual debris. (B) Dermoscopy showing ruin-like appearance and streaks of various colors.
![Figure 2 Patient with laboratory confirmed onychomycosis. (A) Clinical appearance of toenails with onycholysis, nail plate thickening and subungual debris. (B) Dermoscopy showing ruin-like appearance and streaks of various colors.](/cms/asset/e3e5dfd9-3781-4ce0-9d22-5ed0db3a05f7/dcci_a_12152511_f0002_c.jpg)
Table 1 Summary of the Diagnostic Testing Methods
Table 2 Summary of Commonly Used Oral Onychomycosis Medications
Table 3 Summary of FDA-Approved Topical Onychomycosis Medications